Skip to main content
Fig. 2 | Thrombosis Journal

Fig. 2

From: The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study

Fig. 2

Evolution in laboratory coagulation tests, thromboelastography parameters and disease severity scores over 14-day period. Figure shows temporal changes in laboratory coagulation studies, thromboelastography (TEG) parameters and disease severity scores for 21 patients that survived to 14-day evaluation. 30-day survivors and non-survivors are represented as blue and red respectively. Coloured dots represent individual measurements. Grey band represents normal reference ranges as established by the local laboratory and the TEG 6 s operating manual. Asterix (*) indicates significant differences noted between survivors and non-survivors at specific time points. Data is presented as median (IQR), p-values shown in graphs represent changes over 14-day observation for all patients followed up. ULN = upper limit of normal, LLN = lower limit of normal

Back to article page